Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries

<table>Hospitalizations for respiratory-related illness and RSV-positive infection (2005–2012).</table>

Journal of Immunology Research

fig3

Figure 3

Figure 3: Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries 

Figure 3 | Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries 